SynthesisTargeted oncology2024

Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review.

Urszula Żebrowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.